Superconductivity Consortia Proliferate Despite Scientific, Economic Questions

WASHINGTON—Six months after a White House panel concluded that United States competitiveness in high-temperature superconductivity hinged on the successful creation of a half-dozen industrial consortia dedicated to superconductivity research, nearly twice that many either exist or are now proposed. But while organizers tout the vast potential of superconducting electronics and stress the need to beat the Japanese in this field, troubling scientific and economic issues still cloud the pr

Written byChristopher Anderson
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON—Six months after a White House panel concluded that United States competitiveness in high-temperature superconductivity hinged on the successful creation of a half-dozen industrial consortia dedicated to superconductivity research, nearly twice that many either exist or are now proposed. But while organizers tout the vast potential of superconducting electronics and stress the need to beat the Japanese in this field, troubling scientific and economic issues still cloud the prospects of success for U.S. consortia.

The collaborations embrace a variety of approaches. The most visible is the new blue-chip collaboration of IBM, American Telephone and Telegraph, and the Massachusetts Institute of Technology—put together with the help of former IBM vice president Ralph Gomory, who chaired the presidential panel calling for more consortia. The most ambitious is a proposed $1 billion venture by the Council on Superconductivity for American Competitiveness (CSAC), created by former White House science adviser George Key worth. Other ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies